CNS Pharmaceuticals clinical trials we track

Check company identity source

Phase 2 1 trial

TrialDrugs studiedStatusPrimary completion
A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma MultiformeNCT04762069Berubicin, LomustineActive not recruiting2026-04-27Estimated

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters

· 3 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 210 participants (planned). After: 252 participants (actual).

Primary completion date changed

Before: 1 Feb 2026. After: 27 Apr 2026.

Check registry source